gp100:209-217(210M) peptide vaccine

Known as: G9 209-2M, gp100:209-217(210M) 
A synthetic peptide cancer vaccine consisting of amino acid residues 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen, with a… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2010
02419992010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
BACKGROUND Stimulating an immune response against cancer with the use of vaccines remains a challenge. We hypothesized that… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2010
2010
n engl j med 363;8 nejm.org august 19, 2010 781 Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates 4. with tumor… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE To identify prognostic factors associated with survival beyond 4 years and overall response in patients with metastatic… (More)
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Efforts to develop effective cancer vaccines often use combinations of immunogenic peptides to increase the applicability and… (More)
Is this relevant?
2004
2004
Successful immunotherapy with peptide vaccines depends on the in vivo generation of sufficient numbers of anti-tumor T cells with… (More)
Is this relevant?
2003
2003
PURPOSE The purpose of this study was to evaluate the immunological responses and therapeutic effectiveness of immunization with… (More)
Is this relevant?
2002
2002
The functional status of circulating vaccine-induced, tumor-specific T cells has been questioned to explain their paradoxical… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Selective blunting of the status of activation of circulating tumor-specific T cells was invoked to explain their paradoxical… (More)
  • table I
  • table II
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2000
2000
Twenty separate tumor infiltrating lymphocyte (TIL) bulk cultures and a tumor cell line were originated simultaneously from a… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Although in vitro sensitization assays have shown increased melanoma Ag (MA)-specific CTL reactivity after vaccination with MA… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 5
Is this relevant?